<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2020</volume><submitter>Herrera-Calderon O</submitter><funding>Universidad Nacional Mayor de San Marcos</funding><pubmed_abstract>Carvacrol is a phenol monoterpene found in aromatic plants specially in Lamiaceae family, which has been evaluated in an experimental model of breast cancer. However, any proposed mechanism based on its antitumor effect has not been reported. In our previous study, carvacrol showed a protective effect on 7,12-dimethylbenz[&lt;i>α&lt;/i>]anthracene- (DMBA-) induced breast cancer in female rats. The main objective in this research was to evaluate by using &lt;i>in silico&lt;/i> study the carvacrol on HER2, PI3K&lt;i>α&lt;/i>, mTOR, hER-&lt;i>α&lt;/i>, PR, and EGFR receptors involved in breast cancer progression by docking analysis, molecular dynamic, and drug-likeness evaluation. A multilevel computational study to evaluate the antitumor potential of carvacrol focusing on the main targets involved in the breast can</pubmed_abstract><journal>Evidence-based complementary and alternative medicine : eCAM</journal><pagination>8830665</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7607278</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Carvacrol: An &lt;i>In Silico&lt;/i> Approach of a Candidate Drug on HER2, PI3K&lt;i>α&lt;/i>, mTOR, hER-&lt;i>α&lt;/i>, PR, and EGFR Receptors in the Breast Cancer.</pubmed_title><pmcid>PMC7607278</pmcid><pubmed_authors>Arroyo-Acevedo JL</pubmed_authors><pubmed_authors>Quintero-Saumeth J</pubmed_authors><pubmed_authors>Rojas-Armas JP</pubmed_authors><pubmed_authors>Andia-Ayme V</pubmed_authors><pubmed_authors>Yepes-Perez AF</pubmed_authors><pubmed_authors>Figueroa-Salvador L</pubmed_authors><pubmed_authors>Palomino-Pacheco M</pubmed_authors><pubmed_authors>Cieza-Macedo EC</pubmed_authors><pubmed_authors>Herrera-Calderon O</pubmed_authors><pubmed_authors>Ortiz-Sanchez JM</pubmed_authors><pubmed_authors>Pena-Rojas G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Carvacrol: An &lt;i>In Silico&lt;/i> Approach of a Candidate Drug on HER2, PI3K&lt;i>α&lt;/i>, mTOR, hER-&lt;i>α&lt;/i>, PR, and EGFR Receptors in the Breast Cancer.</name><description>Carvacrol is a phenol monoterpene found in aromatic plants specially in Lamiaceae family, which has been evaluated in an experimental model of breast cancer. However, any proposed mechanism based on its antitumor effect has not been reported. In our previous study, carvacrol showed a protective effect on 7,12-dimethylbenz[&lt;i>α&lt;/i>]anthracene- (DMBA-) induced breast cancer in female rats. The main objective in this research was to evaluate by using &lt;i>in silico&lt;/i> study the carvacrol on HER2, PI3K&lt;i>α&lt;/i>, mTOR, hER-&lt;i>α&lt;/i>, PR, and EGFR receptors involved in breast cancer progression by docking analysis, molecular dynamic, and drug-likeness evaluation. A multilevel computational study to evaluate the antitumor potential of carvacrol focusing on the main targets involved in the breast can</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2026-04-07T17:25:46.041Z</modification><creation>2020-11-19T16:57:40Z</creation></dates><accession>S-EPMC7607278</accession><cross_references><pubmed>33163084</pubmed><doi>10.1155/2020/8830665</doi></cross_references></HashMap>